PRMT5 and non-small cell lung carcinoma: While this review focuses on the resistance mechanisms of EZH2 and PRMT5 in NSCLC, it is critical to acknowledge that HMTs constitute a large family with diverse members whose roles in therapeutic resistance remain underexplored.